Stay updated on PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial page
- Check10 days agoChange DetectedThe page has added a section providing helpful links from Pfizer for obtaining contact information for nearby study centers.SummaryDifference0.4%
- Check17 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding a clinical trial for Hidradenitis Suppurativa and the addition of a new treatment model description and version revision.SummaryDifference4%
- Check24 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check60 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.SummaryDifference1%
- Check82 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial page.